ILMN
Illumina, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$218.21
−1.56%Margins
Gross margin
66.8%
EBITDA margin
30.3%
EBIT margin
21.0%
Net margin
18.4%
FCF margin
20.9%
29.1%
Return on equity
12.4%
Return on assets
17.6%
Return on invested capital
0.68x
Asset turnover
$1.1B
Cash from operations
$7.74
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026